Drug class
Omega-3 fatty-acid lipid-modifying agent; antihypertriglyceridaemic
Mechanism of action
The complete mechanism is not fully understood. Proposed actions include reduced hepatic triglyceride synthesis, increased hepatic fatty-acid oxidation and increased plasma lipoprotein-lipase activity.
General use cases
- Adjunct to diet to reduce triglyceride concentrations in adults with severe hypertriglyceridaemia, as specified by the product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
